References
- Adams, L. A. (2015). Non invasive diagnosis of fibrosis in NAFLD, How reliable is it? In: The International Liver Congress. EASL Postgraduate Course: Metabolic Liver Disease, Vienna, 22-–23 April 2015. Vienna, pp. 24–25.
- Anonymous (2014). Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. World Health Organization, Geneva. 56 pp.
- Hussain, A., Gul, M. A., Khalid, M. U. (2019). Validation of novel fibrosis index (NFI) for assessment of liver fibrosis: Comparison with transient elastography (FibroScan). Brit. Med. J. Open Gastroenterol.,6 (1), e000316.10.1136/bmjgast-2019-000316
- Bedossa, P., Dargere, D., Paradis, V. (2003). Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology, 38, 1449–1457.10.1053/jhep.2003.09022
- Bonacini, M., Hadi, G., Govindarajan, S., Lindsay, K. L. (1997). Utility of a discriminant score for diagnosing advanced fibrosis or cirrhosis in patients with chronic hepatitis C virus infection. Amer. J. Gastroenterol., 92 (8), 1302–1304.
- Botros, M., Sikaris, K. A. (2013). The De Ritis ratio: The test of time. Clin. Biochem. Rev., 34 (3), 117–130.
- Cholongitas, E., Senzolo, M., Standish, R., Marelli, L., Quaglia, A., Patch, D., Dhillon, A. P., Burroughs, A. K. (2006). A systematic review of the quality of liver biopsy specimens. Amer. J. Clin. Pathol., 125, 710–721.10.1309/W3XCNT4HKFBN2G0B
- Crawford, J. M. (2002). Liver cirrhosis. In: MacSween, R. N. M., Burt, A. D., Portmann, B. C. (eds.). Pathology of the Liver. 4th ed. Churchill Livingstone, London, pp. 575–619.
- D’Amico, G., Garcia-Tsao, G., Pagliaro, L. (2006). Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J. Hepatol., 44, 217–231.10.1016/j.jhep.2005.10.013
- De Ritis, F., Coltorti, M., Giusti, G. (1957). An enzymic test for the diagnosis of viral hepatitis: The transaminase serum activities. Clin. Chim. Acta, 2 (1), 70–74.10.1016/0009-8981(57)90027-X
- Forns, X., Ampurdančs, S., Llovet, J. M., Aponte, J., Quintó, L., Martínez-Bauer, E., Bruguera, M., Sánchez-Tapias, J. M., Rodés, J. (2002). Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model. Hepatology, 36, 986–992.10.1053/jhep.2002.36128
- Grünhage, F., Lammert, F. (2018). Chapter 19. Assesement of hepatic fibrosis and steatosis. In: Hepatology — a Clinical Textbook. 9th edn. Mauss, Berg, Rockstroh, Sarazzin, Wedemeyer.
- Friedman, S. L. (2008). Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol. Rev., 88, 125–172.10.1152/physrev.00013.2007288853118195085
- Garcia-Tsao, G., Friedman, S., Iredale, J., Pinzani, M. (2010). Now there are many (stages) where before there was one: In search of a patho-physiological classification of cirrhosis. Hepatology, 51 (4), 1445–1449.10.1002/hep.23478288206520077563
- Giannini, E., Botta, F., Fasoli, A., Ceppa, P., Risso, D., Lantieri, P. B., Celle, G., Testa, R. (1999). Progressive liver functional impairment is associated with an increase in AST/ALT ratio. Dig. Dis. Sci., 44, 1249–1253.10.1023/A:1026609231094
- Gines, P., Quintero, E., Arroyo, V., Teres, J., Bruguera, M., Rimola, A., Caballeria, J., Rodes, J., Rozman, C. (1987). Compensated cirrhosis: Natural history and prognostic factors. Hepatology, 7, 122–128.10.1002/hep.18400701243804191
- Huwart, L., Sempoux, C., Vicaut, E., Salameh, N., Annet, L., Danse, E., Peeters, F., Beek, L. C., Rahier, J., Sinkus, R., Horsmans, Y., van Beers, B. E. (2008). Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology, 135, 32–40.10.1053/j.gastro.2008.03.07618471441
- Kelly, M. L., Riordan, S. M., Bopage, R., Lloyd, A. R., Post, J. J. (2018). Capacity of non-invasive hepatic fibrosis algorithms to replace transient elastography to exclude cirrhosis in people with hepatitis C virus infection: A multi-centre observational study. PLOS ONE, 13 (2), e0192763.10.1371/journal.pone.0192763581102029438397
- Kose, S., Ersan, G., Tatar, B., Adar, P., Sengel, B. E. (2015). Evaluation of percutaneous liver biopsy complications in patients with chronic viral hepatitis. Eurasian J. Med., 47,161–164.10.5152/eurasianjmed.2015.107465951626644763
- Lieber, C. S., Weiss, D. G., Morgan, T. R., Paronetto, F. (2006). Aspartate aminotransferase to platelet ratio index in patients with alcoholic liver fibrosis. Amer. J. Gastroenterol., 101, 1500–1508.10.1111/j.1572-0241.2006.00610.x16863553
- Lurie, Y., Webb, M., Cytter-Kuint, R., Shteingart, S., Lederkremer, G. Z. (2015). Non-invasive diagnosis of liver fibrosis and cirrhosis. World J. Gastroenterol., 21, 11567–11583.10.3748/wjg.v21.i41.11567463196126556987
- Machado, N. N., Jackson, T., Ladhani, H. A., Marks, J. M. (2017). Managing complications in endoscopic procedures: Bleeding from a biopsy site. Minerva Chir.,72, 36–43.10.23736/S0026-4733.16.07213-827787483
- Mak, K. M., Chen, L. L., Lee, T.-F. (2013). Codistribution of collagen type IV and laminin in liver fibrosis of elderly cadavers: Immunohistochemical marker of perisinusoidal basement membrane formation. Anat. Rec., 296, 953–964.10.1002/ar.2269423596149
- Minuk, G. Y. (2003). Hepatic regeneration: If it ain’t broke, don’t fix it. Can. J. Gastroenterol., 17 (7), 418–424.10.1155/2003/61540312915914
- Orasan, O. H., Ciulei, G., Cozma, A., Sava, M., Dumitrascu, D. L. (2016). Hyaluronic acid as a biomarker of fibrosis in chronic liver diseases of different etiologies. Clujul. Med., 89 (1), 24–31.10.15386/cjmed-554477746527004022
- Park, G. J., Lin, B. P., Ngu, M. C., Jones, D. B., Katelaris, P. H. (2000). Aspartate aminotransferase. Alanine aminotransferase ratio in chronic hepatitis C infection: Is it a useful predictor of cirrhosis? J. Gastroenterol. Hepatol., 15 (4), 386–390.10.1046/j.1440-1746.2000.02172.x
- Park, S. Y., Kang, K. H., Park, J. H., Lee, J. H., Cho, C. M., Tak, W. Y., Kweon, Y. O., Kim, S. K., Choi, Y. H. (2004). Clinical efficacy of AST/ALT ratio and platelet counts as predictors of degree of fibrosis in HBV infected patients without clinically evident liver cirrhosis. Korean J. Gastroenterol., 43, 246–251.
- Pinzani, M., Rombouts, K., Colagrande, S. (2005). Fibrosis in chronic liver diseases: Diagnosis and management. J. Hepatol., 42 (Suppl. 1), S22–S36.10.1016/j.jhep.2004.12.00815777570
- Poynard, T, Bedossa, P. (1996). An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology, 24, 289–293.10.1002/hep.5102402018690394
- Pohl, A., Behling, C., Oliver, D., Kilani, M., Monson, P., Hassanein, T. (2001). Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Amer. J. Gastroenterol., 96 (11), 3142–3146.10.1111/j.1572-0241.2001.05268.x11721762
- Regev, A., Berho, M., Jeffers, L. J., Milikowski, C., Molina, E. G., Pyrsopoulos, N. T., Feng, Z. Z., Reddy, K. R., Schiff, E. R. (2002). Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Amer. J. Gastroenterol., 97 (10), 2614–2618.10.1111/j.1572-0241.2002.06038.x12385448
- Sande, J. A., Verjee, S., Vinayak, S., Amersi, F., Ghesani, M. (2017). Ultra-sound shear wave elastography and liver fibrosis: A prospective multi-center study. World J. Hepatol., 9, 38–47.10.4254/wjh.v9.i1.38522027028105257
- Shaheen, A. A., Myers, R. P. (2007). Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: A systematic review. Hepatology, 46, 912–921.10.1002/hep.2183517705266
- Sheth, S. G., Flamm, S. L., Gordon, F. D., Chopra, S. (1998). AST/ALT ratio predicts Cirrhosis in patients with chronic hepatitis C virus infection. Amer. J. Gastroenterol., 93, 44–48.10.1111/j.1572-0241.1998.044_c.x9448172
- Soresi, M., Lydia, G., Cervello, M., Licata, A., Montalto, G. (2014). Noninvasive tools for the diagnosis of liver cirrhosis. World J. Gatroenterol., 20 (48), 18131–18150.10.3748/wjg.v20.i48.18131427795225561782
- Sterling, R. K., Lissen, E., Clumeck, N., Sola, R., Correa, M. C., Montaner, J., Sulkowski, M. S., Torriani, F. J., Dieterich, D. T., Thoms, D. L., Messinger, D., Nelson, M., APRICOT Clinical Investigators (2006). Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology, 43, 1317–1325.10.1002/hep.2117816729309
- Tchatalbachev, V. V., Kirkpatrick, D. L., Duff, D. J., Travis, M. D. (2015). Seeding of the rectus sheath with hepatocellular carcinoma after image guided percutaneous liver biopsy using coaxial biopsy needle system. J. Radiol. Case Rep., 9, 18–25.10.3941/jrcr.v9i1.1887439180425926917
- Ustündag, Y., Bilezikēi, B., Boyaciošlu, S., Kayataž, M., Odemir, N. (2000). The utility of AST/ALT ratio as a noninvasive demonstration of the degree of liver fibrosis in chronic HCV patients on long-term haemodialysis. Nephrol. Dial Transplant, 15, 1716–1717.10.1093/ndt/15.10.171611007861
- Vallet-Pichard, A., Mallet, V., Nalpas, B., Verkarre, V., Nalpas, A., Dhalluin-Venier, V., Fontaine, P., Pol, S. (2007). FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology, 46, 32–36.10.1002/hep.2166917567829
- Wai, C. T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., Lok, A. S. (2003). A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology, 38, 518–526.10.1053/jhep.2003.50346
- Williams, A. L., Hoofnagle, J. H. (1998). Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. Gastroenterology, 95, 734–739.10.1016/S0016-5085(88)80022-2